药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Isoprenaline
Apixaban
Cholesterol may increase the excretion rate of Apixaban which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Pazopanib
Cholesterol may increase the excretion rate of Pazopanib which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Simeprevir
Cholesterol may increase the excretion rate of Simeprevir which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Rivaroxaban
Cholesterol may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Nilotinib
Cholesterol may increase the excretion rate of Nilotinib which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Camptothecin
Cholesterol may increase the excretion rate of Camptothecin which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Testosterone undecanoate
Cholesterol may increase the excretion rate of Testosterone undecanoate which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Testosterone enanthate
Cholesterol may increase the excretion rate of Testosterone enanthate which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Testosterone cypionate
Cholesterol may increase the excretion rate of Testosterone cypionate which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Enasidenib
Cholesterol may increase the excretion rate of Enasidenib which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Brigatinib
Cholesterol may increase the excretion rate of Brigatinib which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Delafloxacin
Cholesterol may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Fimasartan
Cholesterol may increase the excretion rate of Fimasartan which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Riociguat
Cholesterol may increase the excretion rate of Riociguat which could result in a lower serum level and potentially a reduction in efficacy.
Isoprenaline
Teriflunomide
Cholesterol may increase the excretion rate of Teriflunomide which could result in a lower serum level and potentially a reduction in efficacy.
Acetophenazine
Prednisolone phosphate
The excretion of Prednisolone phosphate can be decreased when combined with Caprylic acid.
Acetophenazine
Tenofovir
The excretion of Tenofovir can be decreased when combined with Caprylic acid.
Acetophenazine
Relebactam
The excretion of Relebactam can be decreased when combined with Caprylic acid.
Acetophenazine
Edaravone
The excretion of Edaravone can be decreased when combined with Caprylic acid.
Acetophenazine
Baricitinib
The excretion of Baricitinib can be decreased when combined with Caprylic acid.